D. Girling

D. Girling, D. Mitchison, W. Yew, 1992, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Adverse Reactions to Daily and Intermittent Rifampicin Regimens for Pulmonary Tuberculosis in Hong Kong*

D. Girling, W. Fox, R. Tall, 1972, British medical journal.

Amikacin in the treatment of pulmonary tuberculosis.

D. Girling, D. Mitchison, W. Yew, 1983, Tubercle.

The feasibility of using glycosylated recombinant human granulocyte colonystimulating factor (G-CSF) to increase the planned dose intensity of doxorubicin; cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer

D. Girling, D. Machin, N. Bleehen, 1995 .

HLA typing in the Hong Kong Chest Service/British Medical Research Council study of factors associated with the breakdown to active tuberculosis of inactive pulmonary lesions.

D. Girling, D. Mitchison, D. Lowrie, 1988, The American review of respiratory disease.

BTS randomised feasibility study of active symptom control with or without chemotherapy in malignant pleural mesothelioma: ISRCTN 54469112

D. Girling, M. Muers, W. Qian, 2004, Thorax.

A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer.

D. Girling, R. Stephens, N. Thatcher, 2005, Lung cancer.

Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter randomized LU21 trial.

D. Girling, R. Stephens, P. Clark, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party.

P. Fayers, D. Girling, R. Stephens, 1989, Respiratory medicine.

Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party.

P. Fayers, D. Girling, R. Stephens, 1989, British Journal of Cancer.

Survey on the treatment of non-small cell lung cancer (NSCLC) in England and Wales.

M. Parmar, A. Crook, R. Souhami, 1997, The European respiratory journal.

Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma.

D. Girling, R. Stephens, W. Fox, 1985, British Journal of Cancer.

Surgical resection with and without chemotherapy in oesophageal cancer

D. Girling, P. Clark, J. Bancewicz, 2002, The Lancet.

Serodiagnosis of tuberculosis using an ELISA with antigen 5 and a hemagglutination assay with glycolipid antigens. Results in patients with newly diagnosed pulmonary tuberculosis ranging in extent of disease from minimal to extensive.

D. Girling, D. Mitchison, S. Chan, 1990, The American review of respiratory disease.

Pulmonary Fibroplasia in Newborn Babies Treated with Oxygen and Artificial Ventilation

D. Girling, J. Wigglesworth, C. Banerjee, 1971, Archives of disease in childhood.

Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer

D. Girling, R. Stephens, N. Thatcher, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trials in the treatment of cancer of the esophagus.

D. Girling, P. Clark, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acute leukaemia after busulphan.

D. Girling, R. Stephens, W. Fox, 1977, British medical journal.

[Adverse effects of rifampicin].

D. Girling, K. Hitze, 1979, Bulletin of the World Health Organization.

Adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for Small-cell lung cancer

P. Fayers, D. Girling, R. Stephens, 1985 .

Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience

P. Fayers, D. Girling, R. Stephens, 1997 .

Can meta-analyses be trusted?

David Machin, M. Parmar, D. Girling, 1991, The Lancet.

SHORT-COURSE CHEMOTHERAPY OF TUBERCULOSIS

D. Girling, D. Mitchison, P. Stradling, 1976, The Lancet.

Cost Effectiveness of Increasing the Dose Intensity of Chemotherapy with Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer

M. Sculpher, D. Girling, R. Stephens, 2012, PharmacoEconomics.

Hyaline membrane disease, alkali, and intraventricular haemorrhage.

D. Girling, J. Wigglesworth, I. Keith, 1976, Archives of disease in childhood.

Extra-pulmonary tuberculosis.

D. Girling, J. Darbyshire, M. Humphries, 1988, British medical bulletin.

Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial

D. Girling, 1996, The Lancet.

Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial

D. Girling, R. Stephens, A. Gregor, 1997 .

Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.

M. Kris, M. Parmar, L. Stewart, 2015, The Cochrane database of systematic reviews.

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

A. Nicholson, M. Parmar, D. Girling, 2008, The Lancet.

Multicenter randomized controlled trial of the management of unresectable malignant mesothelioma proposed by the British Thoracic Society and the British Medical Research Council.

D. Girling, M. Muers, W. Qian, 2002, Seminars in oncology.

Changes in Heart Rate, Blood Pressure, and Pulse Pressure During Apnoeic Attacks in Newborn Babies

D. Girling, 1972, Archives of disease in childhood.

BABIES BORN ALIVE AFTER INTRAUTERINE TRANSFUSIONS FOR SEVERE RHESUS HAEMOLYTIC DISEASE

D. Girling, J. Scopes, J. S. Wicglesworth, 1972, The Journal of obstetrics and gynaecology of the British Commonwealth.

Persistent Ductus Arteriosus in Ill and Premature Babies

D. Girling, K. Hallidie-Smith, 1971, Archives of disease in childhood.

Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial

D. Girling, R. Stephens, P. Hopwood, 2002, BMJ : British Medical Journal.

Pulmonary fibroplasia in newborn babies treated with oxygen and artificial ventilation.

D. Girling, 1971, Archives of disease in childhood.

The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis.

H. K. Ng, D. Girling, D. Ellard, 1986, American Review of Respiratory Disease.

Adverse Effects of Antitubereulosis Drugs

D. Girling, 2012, Drugs.

Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up.

D. Girling, D. Gibson, A. Casbard, 2004, QJM : monthly journal of the Association of Physicians.

Adverse effects of antituberculosis drugs.

D. Girling, 1982, Drugs.

Cystic degeneration of the telencephalic subependymal germinal layer in newborn infants.

D. Girling, G. D. de León, 1975, Journal of neurology, neurosurgery, and psychiatry.

The symptoms of newly diagnosed pulmonary tuberculosis and patients' attitudes to the disease and to its treatment in Hong Kong.

P. Fayers, D. Girling, W. Fox, 1979, Tubercle.

Value of the silver swaddler in preventing evaporative heat-loss.

D. Girling, J. Scopes, 1970, Lancet.

Clinical Trials in Cancer: Principles and Practice

L. Stewart, D. Girling, R. Stephens, 2003 .

Quality of life assessment in clinical trials--guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience. MRC Cancer Trials Office.

P. Fayers, D. Girling, R. Stephens, 1997, European journal of cancer.

Radiotherapy for inoperable lung cancer.

D. Girling, P. Hoskin, F. Macbeth, 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

Survey of the Administration of quality of life (QL) questionnaires in three multicentre randomised trials in cancer. The Medical Research Council Lung Cancer Working Party the CHART Steering Committee.

M. Parmar, D. Girling, R. Stephens, 1998, European journal of cancer.

Analysis of messy longitudinal data from a randomized clinical trial. MRC Lung Cancer Working Party.

P. Fayers, M. Parmar, D. Girling, 2000, Statistics in medicine.

Side effects of intermittent rifampicin.

D. Girling, W. Fox, 1971, British medical journal.

The hepatic toxicity of isoniazid among rapid and slow acetylators of the drug.

D. Girling, D. Mitchison, A. Nunn, 1978, The American review of respiratory disease.

A national survey of the chemotherapy regimens used to treat small cell lung cancer (SCLC) in the United Kingdom

D. Girling, R. Sambrook, 2001, British Journal of Cancer.

Important issues in planning and conducting multi-centre randomised trials in cancer and publishing their results.

D. Girling, 2000, Critical reviews in oncology/hematology.

Eldana saccharina as a crop pest in Ghana.

D. Girling, 1980 .

Thrips palmi: a literture survey with an annotated bibliography

D. Girling, 1992 .

Possibilities for natural enemies in Heliothis management and the contribution of the Commonwealth Institute of Biological Control.

D. Girling, D. Greathead, W. Reed, 1982 .

Immediate versus delayed thoracic radiotherapy (TRT) in patients with unresectable, locally advanced non-small cell lung cancer (NSCLC) and minimal symptoms: Results of an MRC/BTS randomised trial

D. Girling, P. Hopwood, W. Qian, 2000 .

Radiation myelopathy: estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer. The Medical Research Council Lung Cancer Working Party.

D. Girling, R. Stephens, D. Machin, 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).

Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group).

M. Parmar, L. Stewart, D. Girling, 1998, International journal of radiation oncology, biology, physics.

Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party.

D. Girling, R. Stephens, D. Machin, 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).

Preoperative radiotherapy for esophageal carcinoma.

W Duncan, J F Tierney, M. Parmar, 2005, The Cochrane database of systematic reviews.

O-275 Ifosfamide, carboplatin and etoposide with mid-cycle vincristine (ICE-V) versus standard chemotherapy (C) in patients with small cell lung cancer (SCLC) and good performance status (PS): results of an MRC randomized trial (LU21)

D. Girling, N. Thatcher, W. Qian, 2003 .

Thirty years of Medical Research Council randomized trials in solid tumours.

P. Fayers, M. Parmar, L. Stewart, 1997, Clinical oncology (Royal College of Radiologists (Great Britain)).